Remove FDA Remove Labelling Remove Specialty Pharmacies
article thumbnail

Help Turn Occasional Shoppers into Loyal Customers by Investing in the Front End

Drug Topics

By tailoring your pharmacy to meet the needs of customers across both prescription and over-the-counter (OTC) products, you can transform your store into a long-term community destination for total health and wellness. Private-label brands allow you to deliver the same quality as larger name brands, often at a lower cost. April 2025.

article thumbnail

Obesity Medication Use Remains Low Among Children | ADA 2025

Drug Topics

of YA with obesity were prescribed OMs—predominantly GLP-1s approved for adults but used off label for younger people. Despite the high prevalence of obesity among children and YA, OM utilization remains low,” wrote authors of the abstract. 1 In the final year of the analysis (2024), just 1.5% of adolescents and 5.7%

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Hair Loss Therapy Shows Potential for Regeneration in Phase 2 Trial

Drug Topics

After the randomized portion of the study, patients were eligible to enroll in an open-label extension study for 3 months to assess the long term safety of PP405. Patients applied the therapy or placebo once per day for 4 weeks and were followed for up to 12 weeks.

article thumbnail

Healthy Diet Provides Health Benefits, Even Without Weight Loss

Drug Topics

Image Credit: sonyakamoz - stock.adobe.com "We have been conditioned to equate weight loss with health, and weight loss-resistant individuals are often labeled as failures,” Anat Yaskolka Meir, PhD, postdoctoral research fellow in the department of epidemiology at Harvard Chan School, said in a news release.

article thumbnail

FDA approves omaveloxolone for treatment of Friedreich’s Ataxia

Hospital Pharmacy Europe

In an open label extension trial, after 72 weeks, the response to omaveloxolone compared to placebo was maintained. The post FDA approves omaveloxolone for treatment of Friedreich’s Ataxia appeared first on Hospital Pharmacy Europe.

FDA 97
article thumbnail

Does Blue Cross Blue Shield cover Mounjaro?

The Checkup by Singlecare

Mounjaro (tirzepatide) is a brand-name prescription medication that’s approved by the Food and Drug Administration (FDA) to lower blood sugar levels in people with Type 2 diabetes. Blue Cross Blue Shield doesn’t typically cover Mounjaro for weight loss because it’s considered an off-label use of the drug. How much does Mounjaro cost?

article thumbnail

Does Blue Cross Blue Shield cover Dupixent?

The Checkup by Singlecare

Dupixent (dupilumab) is a brand-name monoclonal antibody drug that is approved by the Food and Drug Administration (FDA) to treat a variety of conditions. However, it’s shown some versatility in recent studies , so doctors might prescribe it off-label for other skin conditions that aren’t FDA approved.